We accelerate digital innovations within life sciences industry

Vision

Our aim is to accelerate software development and digital innovation programmes within healthcare and life sciences, by bringing on board our expertise in health economics, consulting and software solutions development. We build modern, data-driven digital solutions to help manufacturers, academia and regulators to generate the evidence and make better informed decisions leading to improved access to cost-effective and affordable healthcare interventions.

Company background

Digital Health Outcomes is a healthcare consulting and software development company that provides solutions to HEOR, Market Access, Clinical and Regulatory domains. We extend the reach of our services through our partner network of CROs and consulting companies, delivering a stronger mix of expertise, helping our partners to meet the evolving need for delivery of digital solutions.

Team

pic

Founder / Health Economist

Oleksandr Topachevskyi

Designed and implemented digital programme in global pharmaceutical HQ GlaxoSmithKline Vaccines. 10+ years of experience in HEOR and Market Access. Over 20 scientific publications including peer review journals. Postgraduate diploma in Health Economics and Modelling from the University of York, UK.

LinkedIn|ResearchGate
pic

Managing partner / CTO

Andrew Volovyk

Andrew has 15+ years of hands-on experience in full-stack software development, solutions architecture, UI/UX and delivery management with a strong understanding of security, validation, regulatory requirements and standards applied in the life-sciences industry. Including HIPAA and HITECH, 21 CFR Part 11, ISO 27001, ICH GCP. MSc. in Computer Science and Applied Math.

LinkedIn|ResearchGate
pic

Solution Architect

Viktor Turskyi

Victor's role in the company is to provide early technical input to ensure effective scalable development, testing and deployment of the complex software projects. Victor has successfully completed a number of integrations with global IT departments of pharma companies.

LinkedIn
pic

Principal Market Access and HEOR

Mark Connolly, PhD

18+ years’ pharmaceutical / medical device industry experience. Guest Lecturer position with the University of Groningen in the Netherlands. Worked as the International Pricing and Reimbursement Director for Ferring Pharmaceuticals in Switzerland where he supported the branded generics portfolio and innovative medicines. Published over 30 peer-reviewed articles and abstracts.

LinkedIn|ResearchGate
pic

mClinical and real-world registries

Chris Jones. D

Extensive experience in entrepreneurship, management consulting in the pharmaceutical, medical device and healthcare industries, including strategy experience with IBM, Shire, and PA Consulting. Managed all aspects of the startup with partnerships with the largest Ophthalmic CRO, a multibillion-dollar GMP certified manufacturer, and a Tier-1 pharma company.

LinkedIn
pic

Management Consulting & Regulatory

Dalia El-Sherif

Ten years with Genzyme Corporation in digital innovation for rare disease patient-centric marketing and real world research. Twenty years of experience growing businesses and organizations through innovation and technology. Founded and lead development of a commercial real-world data platform in the registry space, including major partnerships with research sponsors and industry.

LinkedIn
pic

Partner

Carina Schey

Carina is a health economist with expertise in the clinical setting, the wider range of health economics services. She has designed and implemented patient-focused, cost-effective services that were provided on behalf of the UK NHS to a wide range of patients in their homes. Carina is currently pursuing research through the University of Groningen in the Netherlands.

LinkedIn|Google Scholar
pic

Strategy and innovation advisor

Allen Lising

25+ years experience in entrepreneurship, product innovation and strategic industry alliances in the pharmaceutical, medical device and healthcare industries. Co-founded Dymaxium and led over 400 interactive solutions. Conceptualized and launched FormularyDecisions, the industry standard for information exchange between biopharma and payers (now part of AmerisourceBergen/Cencora). Led collaboration on strategic partnerships with Academy of Managed Care Pharmacy (AMCP), Institute for Clinical and Economic Review (ICER) and Market Access/HEOR consulting agencies.

LinkedIn
pic

HTA Policy Advisor

Oresta Piniazhko

Oresta is an experienced pharmaceutical policy and implementation practitioner. She holds a PhD degree in Pharmacoeconomics and is currently managing a Health Technology Asessment department at the State Expert Center of the Ministry of Health of Ukraine. Being a dynamic communicator she is also a President at the Ukraine ISPOR Chapter and Students Network.

LinkedIn|ResearchGate
pic

Head of Developoment

Dmytro Ostapovets

Dmytro is leading a team of software developers covering both back and front-end of the technology. He is also educating and mentoring junior personnel to help them on board in development. He hold MSc degree, Cybernetics faculty at Kyiv Shevchenko University.

LinkedIn
pic

Data integration & infrastructure

Oleksandr Simonov

He has 20-year experience in IT industry full of achievements, discoveries and knowledge, successful and ambitious projects, talented people, inspiration and complex tasks. For so many years he never questioned professional choice: development of cutting-edge technologies is my abiding passion, all-consuming hobby and labor of love.

LinkedIn